ImmunoGen CEO on Competitive Cancer Drug Landscape

[cnbc 3000093946]

Daniel Junius, ImmunoGen chairman/CEO, discusses the latest developments in therapeutics for the treatment of cancer.

With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.

Video © and provided by CNBC.

Be the first to comment

Leave a Reply